Investing Profile
Andrew Hack
Your Intro Paths to Andrew Hack
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Andrew is a member of
Hotmail Network
4900 CONNECTIONS
Hotmail Network
4900 CONNECTIONS
Bain Capital Network
275 CONNECTIONS
University of Chicago Network
109 CONNECTIONS
University of Chicago Network
109 CONNECTIONS
Find Andrew Hack on
cbCurrent Investing Position
Bain Capital Ventures Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
8
Andrew Hack is on these Sector & Stage Rankings
Andrew Hack's Investments On Record (6)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Merida Biosciences | Series AApr 2025$120M | $120M |
JenaValve Technology | Series CAug 2022$100M Series UnknownFeb 2020$50M | $270M |
Nuvalent | Series BMay 2021$140M | $190M |
Xilio Therapeutics | Series CFeb 2021$95M | $330M |
Affinivax | Series CJan 2021$230M Series BApr 2020$120M | $350M |
Atea Pharmaceuticals | Series DMay 2020$220M | $220M |
Andrew Hack's Experience
Director of Life Sciences Reify CorporationPresent
Biotechnology Analyst HotmailPresent
Principal MPM BioImpactPresent
Analyst HotmailPresent
Portfolio Manager MillenniumPresent
Chief Financial Officer Editas MedicinePresent
Partner Bain CapitalPresent
Andrew Hack's Education
University of Chicago A.B. Biology
University of Chicago Ph.D. Molecular Genetics and Cell Biology
University of Chicago - The Pritzker School of Medicine M.D. Medicine
Investors who invest with Andrew Hack